Dr. Rosalyn Abbott is an associate professor at Carnegie Mellon University (CMU) in the Biomedical Engineering Department.

First-in-class drugs are often considered a signifier of innovation in drug discovery; however, they can also carry substantial uncertainty. A new comparison of approval data for first-in-class drugs ...

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million people in the world living with HIV. Although the government in Uganda provides ...

Trial of strength at the cellular level: cells are in constant competition with each other and so eliminate diseased or unwanted cells. Cell competition is therefore a central principle for ...

A UT Southwestern study finds that higher cardiorespiratory fitness may slow age-related brain atrophy, preserving cognitive ...

As well as providing energy to the cell, glycolysis also controls cell fate in early embryonic development, laying the ...

A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study ...

For Technology Networks' 2025 Women in Science eBook, we interviewed Robyn Araiza to learn about her career in STEM and how ...

Dr. Sheena Cruickshank’s work in immunology focuses on immune responses and chronic conditions like inflammatory bowel ...

Researchers have identified a novel strategy for treating an aggressive form of leukemia – reprogramming the cancer cells to ...

Researchers have found a rare form of one-dimensional quantum magnetism in a metallic compound for only the second time ever, ...

Some of the most popular potato cultivars were bred many decades ago. The reason for this limited success is the complex ...